Literature DB >> 27784195

Mitochondrial Spare Respiratory Capacity Is Negatively Correlated with Nuclear Reprogramming Efficiency.

Yan Zhou1, Rasha Abdelkadhem Al-Saaidi2, Paula Fernandez-Guerra2, Kristine K Freude3, Rikke Katrine Jentoft Olsen2, Uffe Birk Jensen4, Niels Gregersen2, Poul Hyttel3, Lars Bolund1,5, Lars Aagaard1, Peter Bross2,5, Yonglun Luo1,5.   

Abstract

Nuclear reprogramming efficiency has been shown to be highly variable among different types of somatic cells and different individuals, yet the underlying mechanism remains largely unknown. Several studies have shown that reprogramming of fibroblasts into induced pluripotent stem cells (iPSCs) requires remodeling of mitochondria and a metabolic shift from an oxidative state to a more glycolytic state. In this study, we evaluated the nuclear reprogramming efficiency in relation to mitochondrial bioenergetic parameters of fibroblasts from seven different human individuals. Using the Seahorse extracellular energy flux analyzer, we measured oxygen consumption rate (OCR) profiles of the cells, along with their nuclear reprogramming efficiency into iPSCs. Our results showed that fibroblasts with the lowest mitochondrial spare respiratory capacity (SRC) had the highest nuclear reprogramming efficiency, opposed to fibroblasts with the highest mitochondrial SRC, which showed lowest reprogramming efficiency. Furthermore, we found that targeted fluorescent tagging of endogenous genes (MYH6 and COL2A1) by CRISPR/Cas9-mediated homologous recombination was accompanied by an increase in the SRC level of the modified fibroblasts and impaired reprogramming efficiency. Our findings indicate a negative correlation between high mitochondrial SRC in somatic cells and low reprogramming efficiencies. This type of analysis potentially allows screening and predicting reprogramming efficiency before reprogramming, and further suggests that nuclear reprogramming might be improved by approaches that modulate the SRC.

Entities:  

Keywords:  induced pluripotent stem cells; mitochondrial spare respiratory capacity; nuclear reprogramming; oxidative phosphorylation; reprogramming efficiency

Mesh:

Year:  2016        PMID: 27784195     DOI: 10.1089/scd.2016.0162

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  8 in total

1.  Relationship between serum concentration, functional parameters and cell bioenergetics in IPEC-J2 cell line.

Authors:  Monica Forni; Alessandra Pagliarani; Chiara Bernardini; Cristina Algieri; La Debora Mantia; Augusta Zannoni; Roberta Salaroli; Fabiana Trombetti; Salvatore Nesci
Journal:  Histochem Cell Biol       Date:  2021-03-16       Impact factor: 4.304

2.  Metabolic-targeted Combination Therapy With Dichloroacetate and Metformin Suppresses Glioblastoma Cell Line Growth In Vitro and In Vivo.

Authors:  Laura Korsakova; Jan Aleksander Krasko; Edgaras Stankevicius
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.

Authors:  Harrison E Grace; Patrick Galdun; Edward J Lesnefsky; Franklin D West; Shilpa Iyer
Journal:  Stem Cells Dev       Date:  2019-05-20       Impact factor: 3.272

4.  Fetal programming of polycystic ovary syndrome: Effects of androgen exposure on prenatal ovarian development.

Authors:  Maya Barsky; Jamie Merkison; Pardis Hosseinzadeh; Liubin Yang; Janet Bruno-Gaston; Jay Dunn; William Gibbons; Chellakkan Selvanesan Blesson
Journal:  J Steroid Biochem Mol Biol       Date:  2021-01-27       Impact factor: 4.292

5.  Mitochondrial Processes during Early Development of Dictyostelium discoideum: From Bioenergetic to Proteomic Studies.

Authors:  Monika Mazur; Daria Wojciechowska; Ewa Sitkiewicz; Agata Malinowska; Bianka Świderska; Hanna Kmita; Małgorzata Wojtkowska
Journal:  Genes (Basel)       Date:  2021-04-25       Impact factor: 4.096

Review 6.  Metformin use in pregnancy: promises and uncertainties.

Authors:  Robert S Lindsay; Mary R Loeken
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

7.  Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.

Authors:  Megan Major; Malika K Freund; Kathryn S Burch; Nicholas Mancuso; Michael Ng; Dominic Furniss; Bogdan Pasaniuc; Roel A Ophoff
Journal:  Genet Epidemiol       Date:  2019-05-13       Impact factor: 2.135

8.  Lactate preconditioning promotes a HIF-1α-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts.

Authors:  Alexandra M Kozlov; Asad Lone; Dean H Betts; Robert C Cumming
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.